title: Application of cell engineering technology to the tumour immunotherapeutic drug: a review.
abstract: The concept of cell engineering is frequently mentioned in recent years. It's a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among these products, most can be used for tumor immunotherapy and have been confirmed to be very effective in tumour control or subsidiary treatment. Of them, most common and useful drugs include three sorts; tumour vaccines, cell factors and monoclonal antibodies. The paper will discuss in detail related drugs application advances in tumour immunotherapy.
authors.affiliation: Cell Engineering Research Center, the Fourth Military Medical University, Xi'an, 710032, PR China. chcerc1@fmmu.edu.cn
authors.forename: Z N
authors.initials: ZN
authors.lastname: Chen
authors.forename: J L
authors.initials: JL
authors.lastname: Xing
authors.forename: H J
authors.initials: HJ
authors.lastname: Bian
authors.forename: L
authors.initials: L
authors.lastname: Mi
authors.forename: J L
authors.initials: JL
authors.lastname: Jiang
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001685:Biological Factors / Q000627:therapeutic use; D019496:Cancer Vaccines; D005818:Genetic Engineering; D015316:Genetic Therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001685:Biological Factors; D019496:Cancer Vaccines; D007155:Immunologic Factors